
Apollo Endosurgery APEN
Annual report 2022
added 03-30-2023
Apollo Endosurgery Interest Expense 2011-2026 | APEN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.67 M | 8.32 M | 5.25 M | 4.05 M | 4.06 M | 4.51 M | 18.2 M | 10 M | 18 | 26.6 K | -90.7 K | -4.09 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.2 M | -90.7 K | 4.92 M |
Quarterly Interest Expense Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.16 M | - | 1.22 M | - | 1.34 M | 1.33 M | 1.35 M | - | 1.34 M | 1.32 M | 1.24 M | - | 1.22 M | 669 K | 959 K | - | 1 M | 1.02 M | 960 K | - | 1.01 M | 1.05 M | 1.48 M | - | 1.53 M | 2.52 M | 2.83 M | - | 40 | 40 | - | - | 18 | 18 | - | - | -420 | 27 K | 27 K | - | -47.9 K | 33.3 K | -28.6 K | - | 31.2 K | 4.11 K | -43.6 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.83 M | -47.9 K | 805 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 21.04 | 0.86 % | $ 3.01 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.5 | 1.74 % | $ 121 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.4 | 1.08 % | $ 675 M | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 95.35 | -0.69 % | $ 140 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 302.99 | -0.5 % | $ 8.55 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 47.11 | -0.84 % | $ 7.02 K | ||
|
Electromed
ELMD
|
78 K | $ 29.12 | 1.01 % | $ 246 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 125.29 | -0.39 % | $ 218 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.29 | 2.49 % | $ 123 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.28 | -0.5 % | $ 1.23 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Zynex
ZYXI
|
-440 K | - | - | $ 21.1 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 156.15 | -1.26 % | $ 11.7 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.82 | 2.64 % | $ 84.3 M | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 61.53 | -1.2 % | $ 3.34 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.63 | - | $ 134 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 13.68 | 0.81 % | $ 370 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.56 | -0.22 % | $ 122 M | ||
|
AxoGen
AXGN
|
-199 K | $ 32.73 | - | $ 1.45 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.6 | -1.31 % | $ 1.25 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.76 | -1.11 % | $ 410 M | ||
|
Myomo
MYO
|
21.1 K | $ 0.91 | -1.58 % | $ 6.42 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 87.31 | -0.68 % | $ 11.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 12.42 | -2.05 % | $ 956 M |